Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

482
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
482
Rh Blood Group01:19

Rh Blood Group

4.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

337
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
337
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

417
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
417
Multiple Allele Traits01:49

Multiple Allele Traits

38.8K
The Concept of Multiple Allelism
38.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

750
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
750

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temperature and heat-load exposure effects on preterm births: Insights from a population-based study using distributed lag non-linear models.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

SARS-CoV-2 infection reduces the number of spermatogonial stem cells and dysregulates the transcriptional landscape of the human testis.

Research square·2026
Same author

Promoting lifestyle medicine research in Ghana: lessons learned from Centre for Lifestyle Medicine and Behaviour (CLiMB) Ghana hybrid workshop.

Frontiers in public health·2025
Same author

The active cohort: a population-based smartphone intervention for health outcomes.

Journal of public health (Oxford, England)·2025
Same author

ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): a feasibility study investigating a patient-centred approach to exercise for head and neck cancer patients.

Frontiers in oncology·2025
Same author

HHHFNC Versus NIPPV Delivered by Long Narrow Cannula in Preterm Infants: Randomized Noninferiority Trial.

Pediatric pulmonology·2025
Same journal

Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation.

American journal of perinatology·2026
Same journal

WIC Participation and the Education-related Gap in Adverse Neonatal Outcomes: A Population-based Cohort Study.

American journal of perinatology·2026
Same journal

Low-Dose Aspirin Prophylaxis for Preeclampsia and the Risk of Postpartum Hypertensive Outcomes: A Propensity Score Analysis.

American journal of perinatology·2026
Same journal

Cystic Periventricular Leukomalacia in Preterm Infants: Clinical Risks, Heart Rate, and Oxygenation Patterns.

American journal of perinatology·2026
Same journal

International Consensus Curriculum and Competency Framework for Maternal Point-of-Care Ultrasound Training.

American journal of perinatology·2026
Same journal

From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU.

American journal of perinatology·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K

Does Haptoglobin Phenotype Influence Postnatal Morbidity in Preterm Neonates?

Irena Kessel1, Maayan Leib2, Andrew Levy2

  • 1Department of Neonatology Carmel Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

American Journal of Perinatology
|September 8, 2015
PubMed
Summary
This summary is machine-generated.

Haptoglobin (Hp) phenotype did not influence clinical outcomes or sepsis incidence in preterm infants due to extremely low Hp expression. Further research with larger neonatal cohorts is needed to clarify Hp

More Related Videos

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.6K
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

691

Related Experiment Videos

Last Updated: Apr 4, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.6K
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

691

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Immunology

Background:

  • Haptoglobin (Hp) is an acute phase protein with antioxidant and anti-inflammatory properties.
  • Different Hp phenotypes exhibit varying proinflammatory and anti-inflammatory effects.
  • Inflammation and oxidative stress are key factors in premature infant pathophysiology.

Purpose of the Study:

  • To investigate the influence of Haptoglobin (Hp) phenotype on clinical manifestations and sepsis incidence in premature infants.
  • To evaluate the association between Hp phenotype and common neonatal morbidities.

Main Methods:

  • Prospective evaluation of 122 preterm infants (born before 35 weeks gestational age).
  • Assessment of Haptoglobin (Hp) phenotype and clinical events, including sepsis, necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage, and retinopathy of prematurity.
  • Observation of participants until hospital discharge.

Main Results:

  • No significant association was found between Haptoglobin (Hp) phenotype and the occurrence of clinical events or sepsis.
  • Extremely low expression of Haptoglobin (Hp) protein was observed in the study population.
  • A non-statistically significant trend towards more septic episodes was noted in infants with a birth weight greater than 1,500g.

Conclusions:

  • Extremely low Haptoglobin (Hp) expression may explain the absence of a correlation between Hp phenotype and sepsis in preterm infants.
  • Further research with larger neonatal populations is necessary to elucidate the role of Hp phenotype in preterm infant morbidity.